Article Information
History
- August 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Michel Thépaut1,4,
- Joanna Luczkowiak2,4,
- Corinne Vivès1,
- Nuria Labiod2,
- Isabelle Bally1,
- Fátima Lasala2,
- Yasmina Grimoire1,
- Daphna Fenel1,
- Sara Sattin3,
- Nicole Thielens1,
- Guy Schoehn1,
- Anna Bernardi3,
- Rafael Delgado2,* and
- Franck Fieschi1,*
- 1Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, 38000 Grenoble, France
- 2Instituto de Investigación Hospital Universitario 12 de Octubre (imas12), Universidad Complutense School of Medicine, 28041 Madrid, Spain
- 3Universita’ degli Studi di Milano, Dipartimento di Chimica, via Golgi 19, 20133, Milano, Italy
- ↵*Correspondance: rafael.delgado{at}salud.madrid.org, franck.fieschi{at}ibs.fr
↵4 These authors contributed equally
Posted August 10, 2020.
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
